Hepatic activation of irinotecan predicts tumour response in patients with colorectal liver metastases treated with DEBIRI: exploratory findings from a phase II study
Titel:
Hepatic activation of irinotecan predicts tumour response in patients with colorectal liver metastases treated with DEBIRI: exploratory findings from a phase II study
Auteur:
Jones, R. P. Sutton, P. Greensmith, R. M. D. Santoyo-Castelazo, A. Carr, D. F. Jenkins, R. Rowe, C. Hamlett, J. Park, B. K. Terlizzo, M. O’Grady, E. Ghaneh, P. Fenwick, S. W. Malik, H. Z. Poston, G. J. Kitteringham, N. R.